Changing patterns of bacterial profile and antimicrobial resistance in high-risk patients during the COVID-19 pandemic at a tertiary oncology hospital.

Rasha M Abdel-Hamid, Hadir A El-Mahallawy, Rasha M Allam, Mai M Zafer, Marwa Elswify

Abstract read

In one paragraph

Article in Archives of microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rasha M Abdel-HamidClinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt. rasha.elgyar@nci.cu.edu.eg.ORCID http://orcid.org/0000-0002-2177-6153

Hadir A El-MahallawyClinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.ORCID http://orcid.org/0000-0003-2887-8125

Rasha M AllamCancer Epidemiology and Biostatistics Department, National Cancer Institute, Cairo University, Cairo, Egypt.ORCID http://orcid.org/0000-0002-4537-0393

Mai M ZaferMicrobiology and Immunology Department, Faculty of Pharmacy, Ahram Canadian University, Cairo, Egypt.ORCID http://orcid.org/0000-0002-4507-376X

Marwa ElswifyClinical Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.ORCID http://orcid.org/0009-0007-6434-4311

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The widespread evolution of phenotypic resistance in clinical isolates over the years, coupled with the COVID-19 pandemic onset, has exacerbated the global challenge of antimicrobial resistance. This study aimed to explore changes in bacterial infection patterns and antimicrobial resistance during the COVID-19 pandemic. This study involved the periods before and during COVID-19: the pre-pandemic and pandemic eras. The surveillance results of bacterial isolates causing infections in cancer patients at an Egyptian tertiary oncology hospital were retrieved. The Vitek

Indexed as

Anti-Bacterial AgentsCOVID-19Drug Resistance, BacterialSARS-CoV-2Tertiary Care CentersBacteriaBacterial InfectionsCancer Care FacilitiesEgyptGram-Negative BacteriaGram-Positive BacteriaHumansMicrobial Sensitivity TestsNeoplasmsPandemicsAnti-Bacterial AgentsCOVID-19 pandemicGram-negative bacteriaGram-positive bacteriaHematological malignanciesOncology patientsResistance patterns

Identifiers

PMID38722362

DOI10.3390/jcm9092744

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.